Spreading of alu methylation to the promoter of the mlh1 gene in gastrointestinal cancer

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Wang, Xiyin ^a   Fan, Jing ^a   Liu, Dong ^a   Fu, Siqing ^a   Ingvarsson, Sigurdur ^b   Chen, Huiping ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b UNIVERSITY OF ICELAND   (Iceland)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN MLH1; TRANS ACTING FACTOR; MLH1 PROTEIN, HUMAN; NUCLEAR PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ALU SEQUENCE; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER TISSUE; COLORECTAL CANCER; CONTROLLED STUDY; CPG ISLAND; DEMETHYLATION; DIGESTIVE SYSTEM CANCER; DNA METHYLATION; EXON; GENE SEQUENCE; GENOME; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRON; PROMOTER REGION; RETROPOSON; STOMACH CANCER; GASTROINTESTINAL TUMOR; GENETIC SCREENING; GENETICS; IMMUNOHISTOCHEMISTRY; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; TUMOR CELL LINE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ALU ELEMENTS; BASE SEQUENCE; CELL LINE, TUMOR; CPG ISLANDS; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; EXONS; GASTROINTESTINAL NEOPLASMS; GENETIC TESTING; HUMANS; IMMUNOHISTOCHEMISTRY; INTRONS; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PROMOTER REGIONS, GENETIC;

EID: 80053994167     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025913     Document Type: Article

References (15)

1. Goodfellow PJ, Buttin BM, Herzog TJ, Rader JS, Gibb RK, et al. (2003) Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers. Proc Natl Acad Sci U S A 100: 5908-5913.
2. Deng G, Chen A, Hong J, Chae HS, Kim YS, (1999) Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression. Cancer Res 59: 2029-2033.
3. Kang GH, Lee S, Shim YH, Kim JC, Ro JY, (2002) Profile of methylated CpG sites of hMLH1 promoter in primary gastric carcinoma with microsatellite instability. Pathol Int 52: 764-768.
4. Chen H, Taylor NP, Sotamaa KM, Mutch DG, Powell MA, et al. (2007) Evidence for heritable predisposition to epigenetic silencing of MLH1. Int J Cancer 120: 1684-1688.
5. Mei M, Liu D, Dong S, Ingvarsson S, Goodfellow PJ, et al. (2010) The MLH1-93 promoter variant influences gene expression. Cancer Epidemiol 34: 93-95.
6. Xiang S, Liu Z, Zhang B, Zhou J, Zhu BD, et al. (2010) Methylation status of individual CpG sites within Alu elements in the human genome and Alu hypomethylation in gastric carcinomas. BMC Cancer 10: 44.
7. Turker MS, Bestor TH, (1997) Formation of methylation patterns in the mammalian genome. Mutat Res 386: 119-130.
8. Graff JR, Herman JG, Myöhänen S, Baylin SB, Vertino PM, (1997) Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation. J Biol Chem 272: 22322-22329.
9. Brandeis M, Frank D, Keshet I, Siegfried Z, Mendelsohn M, et al. (1994) Sp1 elements protect a CpG island from de novo methylation. Nature 371: 435-438.
10. Macleod D, Charlton J, Mullins J, Bird AP, (1994) Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island. Genes Dev 8: 2282-2292.
11. Mummaneni P, Bishop PL, Turker MS, (1993) A cis-acting element accounts for a conserved methylation pattern upstream of the mouse adenine phosphoribosyltransferase gene. J Biol Chem 268: 552-558.
12. Mummaneni P, Walker KA, Bishop PL, Turker MS, (1995) Epigenetic gene inactivation induced by a cis-acting methylation center. J Biol Chem 270: 788-792.
13. Smiraglia DJ, Rush LJ, Frühwald MC, Dai Z, Held WA, et al. (2001) Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies. Hum Mol Genet 10: 1413-1419.
14. Tellez CS, Shen L, Estécio MR, Jelinek J, Gershenwald JE, et al. (2009) CpG island methylation profiling in human melanoma cell lines. Melanoma Res 19: 146-155.
15. Igarashi S, Suzuki H, Niinuma T, Shimizu H, Nojima M, et al. (2010) A novel correlation between LINE-1 hypomethylation and the malignancy of gastrointestinal stromal tumors. Clin Cancer Res 16: 5114-5123.